Correlation Between Purple Biotech and Lumos Pharma
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Lumos Pharma, you can compare the effects of market volatilities on Purple Biotech and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Lumos Pharma.
Diversification Opportunities for Purple Biotech and Lumos Pharma
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Purple and Lumos is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of Purple Biotech i.e., Purple Biotech and Lumos Pharma go up and down completely randomly.
Pair Corralation between Purple Biotech and Lumos Pharma
Given the investment horizon of 90 days Purple Biotech is expected to under-perform the Lumos Pharma. In addition to that, Purple Biotech is 1.93 times more volatile than Lumos Pharma. It trades about -0.02 of its total potential returns per unit of risk. Lumos Pharma is currently generating about 0.03 per unit of volatility. If you would invest 336.00 in Lumos Pharma on November 4, 2024 and sell it today you would earn a total of 98.00 from holding Lumos Pharma or generate 29.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 93.33% |
| Values | Daily Returns |
Purple Biotech vs. Lumos Pharma
Performance |
| Timeline |
| Purple Biotech |
| Lumos Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Purple Biotech and Lumos Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Purple Biotech and Lumos Pharma
The main advantage of trading using opposite Purple Biotech and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
| Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics | Lumos Pharma vs. Silo Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |